LEO Pharma

In 2011 LEO Pharma, a company that had only worked with contract research organizations, took a leap of faith on an academic lab. The result was a 14-step synthesis of ingenol, guided through biweekly calls by Jakob Felding’s team, and a partnership that went on to phorbol, thapsigargin, ouabagenin, calcipotriol and cyclopamine. Few companies have done more to show what patient, ambitious collaboration with academia can achieve.

Ballerup, Denmark

Papers together
13
Years
2013–2024
Co-authors
8
The record

All 13 papers with LEO Pharma

All partners →
  1. Nickel-Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers

    Angew. Chem. Int. Ed. 2024 · doi:10.1002/ange.202314617 · In our publications

    • Bristol Myers Squibb Daniel Ridge, Jack L. Sloane, Kevin W. Gillman, Martins S. Oderinde, Maximilian D. Palkowitz, Megan A. Emmanuel, Michael D. Mandler
    • LEO Pharma Nadia Nasser Petersen, Pablo Martín-Gago, Sebastian Clementson
    • Enamine Pavel K. Mykhailiuk
    • Biogen Michael C. Nicastri, Philippe N. Bolduc
  2. Convergent Total Synthesis of (−)-Cyclopamine

    J. Am. Chem. Soc. 2023 · doi:10.1021/jacs.3c09085 · In our publications

    • LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
  3. Complex Molecule Synthesis by Electrocatalytic Decarboxylative Cross-Coupling

    Nature 2023 · doi:10.1038/s41586-023-06677-2 · In our publications

    • Bristol Myers Squibb Martins S. Oderinde, Maximilian D. Palkowitz, Michael D. Mandler, T. G. Murali Dhar
    • Pfizer Daniel C. Schmitt, Michael R. Collins
    • LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
    • Biogen Philippe N. Bolduc, TeYu Chen
    • Lilly Daniel C. Schmitt
  4. Overcoming Limitations in Decarboxylative Arylation via Ag–Ni Electrocatalysis

    J. Am. Chem. Soc. 2022 · doi:10.1021/jacs.2c08006 · In our publications

    • Bristol Myers Squibb Benjamin Vokits, Hao Zhang, Jeremy M. Richter, Martins S. Oderinde, Michael A. Poss, Michael D. Mandler, Peter T. W. Cheng, Scott A. Shaw, T. G. Murali Dhar, Yeheng Zhu
    • Pfizer Martin Bravo, Michael R. Collins, Ryan Schioldager
    • LEO Pharma Nadia Nasser Petersen, Sebastian Clementson
    • Enamine Pavel K. Mykhailiuk
    • Biogen Philippe N. Bolduc, TeYu Chen, Vanna D. Blasczak
    • Minakem Pierre-Georges Echeverria
  5. Divergent Synthesis of Thapsigargin Analogs

    Bioorg. Med. Chem. Lett. 2018 · doi:10.1016/j.bmcl.2018.03.065 · In our publications

    • LEO Pharma Georg Dünstl, Jakob Felding
  6. Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs

    ACS Cent. Sci. 2017 · doi:10.1021/acscentsci.7b00420 · In our publications

    • LEO Pharma Bjarne Nørremark, Georg Dünstl, Jakob Felding, Lars Jørgensen
  7. C–H Oxidation of Ingenanes Enables Potent and Selective Protein Kinase C Isoform Activation

    Angew. Chem. Int. Ed. 2015 · doi:10.1002/anie.201507977 · In our publications

    • LEO Pharma Georg Dünstl, Jakob Felding
    • Kemxtree Swaminathan R. Natarajan

Our co-authors at LEO Pharma

Sebastian ClementsonGeorg DünstlJakob FeldingLars JørgensenPablo Martín-GagoBjarne NørremarkNadia Nasser PetersenTine Skak-Nielsen

Some of these papers were shared with 7 other partners: Bristol Myers Squibb, Enamine, Biogen, Pfizer, Eli Lilly and Company, Minakem, Kemxtree.

Work with us

Interested in collaborating with the Baran lab?

If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.

Email Phil

or write to pbaran@scripps.edu